This Pharma Company’s Hyderabad Facility Meets International GMP Standards; Stock Price Gains

Sudarshan Pharma Industries Limited claimed that it received key global certifications for its Hyderabad, Telangana, manufacturing plant. The company announced to the stock exchanges on Wednesday that it has strengthened its quality and compliance standards, marking a major achievement.

As of 1:30 PM IST on February 19, 2026, Sudarshan Pharma Industries Ltd (BSE: 543828) is trading at Rs 26.00, up 1.25% from its previous close. With a 52-week trading range of Rs 18.50 to Rs 35.40, the stock is in the small-cap category with a market valuation of around Rs 625.71 Crore.

For the production of API Intermediates and Active Pharmaceutical Ingredients (APIs), the Hyderabad plant, located in IDA-Medchal, has been granted the Certificate of Compliance for Good Manufacturing Practice (GMP). This certification, which was given by UK Certification & Inspection Limited, indicates to the fact that the company's production procedures follow internationally recognized GMP guidelines.

The facility's adherence to strict quality controls, standardized production processes, and strong documentation systems that ensure product safety and consistency has been verified by the GMP certification.

Staunchly Management and System Services Private Limited has confirmed that Sudarshan Pharma Industries complies with the ISO 9001:2015 Quality Management System standard in addition to its GMP certification. The company's robust quality management system, which prioritizes operational effectiveness, risk management, and continuous development, is reflected in this certification, which covers the production of APIs and API Intermediates.

Both certificates are subject to ongoing surveillance audits and are valid until February 11, 2029.

About 104,000 shares have been traded so far in the day, with the stock opening at Rs 25.50 and ranging between Rs 25.40 and Rs 26.13 intraday. According to Dhan, the stock is still in an intraday upswing and is trading above its 50-day moving average (DMA) of Rs 23.83, but it is still below its 200-DMA of Rs 27.54, suggesting that market sentiment is currently favorable.

Founded in 2008, Sudarshan Pharma Industries Limited is an ISO-certified company with headquarters in Mumbai that specializes in the production, distribution, and outsourcing of API, specialty chemicals, and generic pharmaceutical formulations. The company has established itself in both foreign and Indian markets.

The UK, Australia, Uzbekistan, Syria, Oman, Taiwan, and MENA regions are among the countries to which its products have been exported. In addition to these operations, the company offers generic pharmaceutical formulations and medications to hospitals, government agencies, non-governmental organizations, and healthcare institutions through contract manufacturing, outsourcing, and supply.